183 related articles for article (PubMed ID: 18360749)
1. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.
Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R
Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
[TBL] [Abstract][Full Text] [Related]
4. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F
Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging.
Aliaga A; Rousseau JA; Ouellette R; Cadorette J; van Lier JE; Lecomte R; Bénard F
Nucl Med Biol; 2004 Aug; 31(6):761-70. PubMed ID: 15246367
[TBL] [Abstract][Full Text] [Related]
6. Automated synthesis of 11beta-methoxy-4,16alpha-[16alpha-(18)F]difluoroestradiol (4F-M[(18)F]FES) for estrogen receptor imaging by positron emission tomography.
Ahmed N; Langlois R; Rodrigue S; Bénard F; van Lier JE
Nucl Med Biol; 2007 May; 34(4):459-64. PubMed ID: 17499736
[TBL] [Abstract][Full Text] [Related]
7. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
[TBL] [Abstract][Full Text] [Related]
8. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.
Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE
Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and breast tumor uptake of 16alpha-[18F]-fluoro-17beta-estradiol in rat.
Sasaki M; Fukumura T; Kuwabara Y; Yoshida T; Nakagawa M; Ichiya Y; Masuda K
Ann Nucl Med; 2000 Apr; 14(2):127-30. PubMed ID: 10830531
[TBL] [Abstract][Full Text] [Related]
10.
Salem K; Kumar M; Powers GL; Jeffery JJ; Yan Y; Mahajan AM; Fowler AM
Radiology; 2018 Mar; 286(3):856-864. PubMed ID: 28956736
[TBL] [Abstract][Full Text] [Related]
11.
Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
[TBL] [Abstract][Full Text] [Related]
12. Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer
Paquette M; Lavallée É; Phoenix S; Ouellet R; Senta H; van Lier JE; Guérin B; Lecomte R; Turcotte ÉE
J Nucl Med; 2018 Feb; 59(2):197-203. PubMed ID: 28798032
[TBL] [Abstract][Full Text] [Related]
13.
Kumar M; Salem K; Michel C; Jeffery JJ; Yan Y; Fowler AM
J Nucl Med; 2019 Sep; 60(9):1247-1252. PubMed ID: 30850489
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the alkyl side chain length of fluorine-18-labeled 7α-alkyl-fluoroestradiol.
Okamoto M; Shibayama H; Naka K; Kitagawa Y; Ishiwata K; Shimizu I; Toyohara J
Nucl Med Biol; 2016 Aug; 43(8):512-9. PubMed ID: 27289329
[TBL] [Abstract][Full Text] [Related]
15. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
16. Effective specific activities determined by scintillation proximity counting for production runs of [(18)F]FES and 4F-M[(18)F]FES.
Beauregard JM; Croteau E; Ahmed N; Ouellette R; van Lier JE; Bénard F
Nucl Med Biol; 2007 Apr; 34(3):325-9. PubMed ID: 17383582
[TBL] [Abstract][Full Text] [Related]
17. Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol.
Peterson LM; Mankoff DA; Lawton T; Yagle K; Schubert EK; Stekhova S; Gown A; Link JM; Tewson T; Krohn KA
J Nucl Med; 2008 Mar; 49(3):367-74. PubMed ID: 18287268
[TBL] [Abstract][Full Text] [Related]
18. 11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity.
Pomper MG; VanBrocklin H; Thieme AM; Thomas RD; Kiesewetter DO; Carlson KE; Mathias CJ; Welch MJ; Katzenellenbogen JA
J Med Chem; 1990 Dec; 33(12):3143-55. PubMed ID: 1701833
[TBL] [Abstract][Full Text] [Related]
19. Cross-Species Physiological Assessment of Brain Estrogen Receptor Expression Using
Paquette M; Phoenix S; Lavallée É; Rousseau JA; Guérin B; Turcotte ÉE; Lecomte R
Mol Imaging Biol; 2020 Oct; 22(5):1403-1413. PubMed ID: 32699974
[TBL] [Abstract][Full Text] [Related]
20. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]